Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Famotidine,Calcium Carbonate,Magnesium Hydroxide
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Akums Launches Dual Action Heartburn Relief Chewable Tablet
Details : Dual action heartburn relief chewable tablet, consisting Famotidine (H2 receptor antagonist), Calcium Carbonate and Magnesium Hydroxide have been approved and launched in indian market.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 10, 2024
Lead Product(s) : Famotidine,Calcium Carbonate,Magnesium Hydroxide
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Gastroenterology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 05, 2024
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Single Arm Study Comparing ACC Supplement to CCS in Management of Hypoparathyroidism
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 01, 2024
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Sponsor : Taipei Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
April 13, 2023
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Sponsor : Taipei Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 25, 2021
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Nephrology
Study Phase : Phase II
Sponsor : Canadian Institutes of Health Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
November 26, 2013
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Nephrology
Highest Development Status : Phase II
Sponsor : Canadian Institutes of Health Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 22, 2013
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 20, 2013
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Endocrinology
Study Phase : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 20, 2013
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Endocrinology
Highest Development Status : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Nephrology
Study Phase : Undisclosed
Sponsor : Sanofi | Purdue University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
July 13, 2010
Lead Product(s) : Calcium Carbonate
Therapeutic Area : Nephrology
Highest Development Status : Undisclosed
Sponsor : Sanofi | Purdue University
Deal Size : Inapplicable
Deal Type : Inapplicable